| pubmed-article:11035127 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11035127 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:11035127 | lifeskim:mentions | umls-concept:C1959609 | lld:lifeskim |
| pubmed-article:11035127 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:11035127 | lifeskim:mentions | umls-concept:C0035448 | lld:lifeskim |
| pubmed-article:11035127 | lifeskim:mentions | umls-concept:C0439793 | lld:lifeskim |
| pubmed-article:11035127 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:11035127 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11035127 | pubmed:dateCreated | 2000-11-13 | lld:pubmed |
| pubmed-article:11035127 | pubmed:abstractText | To evaluate and to compare the association of two types of autoantibodies-rheumatoid factors (RF) and anti-filaggrin antibodies (AFA)-with clinical severity and joint damage progression in rheumatoid arthritis (RA) patients. | lld:pubmed |
| pubmed-article:11035127 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11035127 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11035127 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11035127 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11035127 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11035127 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11035127 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11035127 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11035127 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11035127 | pubmed:issn | 1462-0324 | lld:pubmed |
| pubmed-article:11035127 | pubmed:author | pubmed-author:SeitzMM | lld:pubmed |
| pubmed-article:11035127 | pubmed:author | pubmed-author:BanHH | lld:pubmed |
| pubmed-article:11035127 | pubmed:author | pubmed-author:PernegerT VTV | lld:pubmed |
| pubmed-article:11035127 | pubmed:author | pubmed-author:Roux-LombardP... | lld:pubmed |
| pubmed-article:11035127 | pubmed:author | pubmed-author:GuerneP APA | lld:pubmed |
| pubmed-article:11035127 | pubmed:author | pubmed-author:TiercyJ MJM | lld:pubmed |
| pubmed-article:11035127 | pubmed:author | pubmed-author:MikhnevitchEE | lld:pubmed |
| pubmed-article:11035127 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11035127 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:11035127 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11035127 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11035127 | pubmed:pagination | 1082-8 | lld:pubmed |
| pubmed-article:11035127 | pubmed:dateRevised | 2007-9-6 | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:meshHeading | pubmed-meshheading:11035127... | lld:pubmed |
| pubmed-article:11035127 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11035127 | pubmed:articleTitle | Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis. | lld:pubmed |
| pubmed-article:11035127 | pubmed:affiliation | Division of Rheumatology, Department of Internal Medicine, University Hospital, Geneva, Switzerland. | lld:pubmed |
| pubmed-article:11035127 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11035127 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11035127 | lld:pubmed |
